1. INTRODUCTION
2. SCIENTIFIC AND REGULATORY ASPECTS OF NANOMATERIALS EVALUATION
2.1. Scientific challenges of evaluating dossiers containing nanoforms
2.2. Scientific challenges in dealing with the risk of nanomaterials
2.3. Feedback from the first meeting of the “Group Assessing Already Registered Nanomaterials” (GAARN)
2.4. Nanomaterials under REACH
2.5. Regulatory status of dossiers containing nanoforms
2.6. Key points of discussion
2.6.1. Discussion on points 2.1, 2.2 and 2.3
2.6.2. Discussion on points 2.4 and 2.5
3. NANOMATERIALS WORKING GROUP
4. CONCLUSIONS AND FOLLOW-UP
APPENDIX 1